Leaving the Echo Chamber: What We Learned About Menopause at Work

Most workplace menopause conversations happen in the same rooms, with the same people, and they end with the same conclusions. That is the challenge with echo chambers. 

And, because the conversation about menopause rarely leaves those rooms, the field has spent five years describing the same gap without closing it. Just more of the same check box certifications and underutilized point solutions we see in other siloed workplace well-being initiatives.

We built this study, in an attempt to break that pattern.

Through The Fuchsia Tent’s research partnership with the Society for Women’s Health Research, we sought guidance from the people who are usually missing from this work: men, women from underrepresented backgrounds, frontline and deskless workers, decision-makers who control budgets, and women who have not yet entered the menopausal transition but will. Menopause is as certain as death and taxes for women who live long enough. Everyone has a stake in this conversation.

So we expanded on our survey learnings through regional roundtables, in four very different cities. We listened way more than we spoke.

The quantitative arm of our joint mixed-methods study was fielded nationally from March 16 to April 16, 2026. Over 1,100 people participated in the survey. Our sample included 40% men, a group that rarely gets asked about menopause much less at work. In addition to including men, nearly half of the women in the sample identified as being from typically underrepresented backgrounds. To complete this research we devised an intentional sampling strategy, ensuring every subgroup we wanted to analyze was statistically powered. Data that primarily captures the lived experience of only one group of employees doesn't tell a complete story.

Menopause at Work: What We Measured

The survey measured the following dimensions of work: 

• Employer readiness
• Employee experience
• Symptom impact
• Disclosure behavior
• Awareness of clinical pathways
• And access to care. 

Work Environments

Our respondents spanned industries from healthcare, technology, and professional services, to government, education, manufacturing, and retail. Employer size ranges from small businesses to enterprises with tens of thousands of employees, and respondents were geographically distributed across the United States. The full demographic profile and findings will be released in the co-branded research report this fall, with peer-reviewed publication beginning in late 2026.

Between April 24 and May 8, we convened four regional roundtables:

• Boston, Massachusetts at William James College
• Houston, Texas at Texas Children’s Pavilion for Women
• Chicago, Illinois at The Arts Club of Chicago
• Los Angeles, California at WME Agency

These cities were chosen deliberately for their different political structures, industry mixes and diverse cultures. If the patterns coming out of the survey only held up in Boston and Los Angeles, that would tell us something. If they held up everywhere, that would tell us something more important.

Each room mixed individuals in their twenties through their sixties and beyond. We saw C-suite executives mingling with individual contributors, clinicians hanging with HR leaders, as well as policy experts and advocates connecting with frontline workers. As researchers we worried we wouldn't have enough people, or the right mix. We had both, worrying proved pointless.

Our roundtables saw women who were actively experiencing the menopausal transition as well as those who have not yet experienced it, and people who never will. The conversations included racially and ethnically diverse voices across White, Black or African American, Asian, Hispanic or Latino, and Middle Eastern or North African communities. We saw deep agreement on what hurts, and wildly different experiences of it.

The Men Showed Up Too

We recruited men in every city and succeeded in every city except Houston. Men matter in the menopause discussion, especially at work where they make up the majority of the C-suite. Many would like to call menopause at work a women's issue and leave it at that. Menopause is a systems issue which means everyone is accountable, regardless of gender. 

Participants held decision-making authority over benefits design, health and well-being programs, workplace policy, state and local government, and people leadership. The organizations they came from ranged from fewer than fifteen employees to more than five thousand, spanning healthcare, education, technology, professional services, government, entertainment, and beyond.

The full thematic analysis will be shared in the research report and the trade/peer-reviewed papers that will follow in Fall 2026. Across four very different cities, with four very different audiences the conversation kept returning to the same tension points.

• The gap between menopause awareness and meaningful employer action. 
• The language problem, and what organizations are willing to say out loud.
• The fragmentation of clinical care that turns menopause symptoms into ten unrelated problems instead of one. 
• The realities of frontline and deskless work, where flexibility is not a benefit most employers offer. 
• And the wildly uneven state of menopause policy across states and federal agencies.

None of this information was new or shocking. What is new is the evidence base behind it, and the fact that the evidence came from people who do not usually sit at this table.

Menopause does not need another awareness campaign or siloed point solution/training. Companies are missing operational guidance that tells employers, policymakers, and healthcare leaders how to properly support midlife women.

At The Fuchsia Tent we call this guidance The 3H Framework™.

The 3H Framework is the operational architecture we have been building inside The Fuchsia Tent since we launched. 

The 3Hs

H1: Healthcare illuminates the invisibility of menopause at work. Symptoms are fragmented and get treated as ten unrelated conditions. Benefits are fragmented and not seen as menopause care. Companies are left to believe expensive point solutions are the only option, which isn't the case.

H2: Help speaks to the lack of compassionate leadership and structured dialogue frameworks. Organizations are not equipped to have difficult conversations which extends to menopause. Everyone suffers waiting for women to proactively disclose a life transition steeped in ageism and sexism.

H3: HRT & FDA-Approved Non-Hormonal Therapy Access uncovers what happens when organizations fail to institute drug utilization reviews, leaving women to pay $30 to $60 a month for generic HRT, or step through two additional therapies before getting access to novel agents.

The survey and the roundtables are two halves of the same study that will be shared in a research report this fall. In the meantime you can download 3H Framework white paper "Menopause at Work: Why Integration Beats Innovation." 

Thank you to SWHR for being the partner who said yes to building this study the right way, and to the partners in each city who opened their doors and their rosters to make these roundtables possible:

• Dr. Darlene Piva, William James College

• Dr. Gracia Wynne Duncan, Texas Children’s Hospital Pavilion for Women

• Julie Fedeli and Pamela DeRose, Midlife Upgrade

• Hannah Linkenhoker, William Morris Endeavor (WME) Agency